Company Overview and News

9
Shake-up at GLCs

16h thestar.com.my
The new government has clearly said that there is a need to review the role of GLCs and the remuneration paid out to their top executives
1155 1023 PBLOF MLYBY 6888 MLYNF 55BC AXXTF 1295 CBQS CIMDF

2
PNB dismisses speculation about Wahid’s resignation

2018-06-22 theedgemarkets
KUALA LUMPUR: State-owned fund manager Permodalan Nasional Bhd (PNB) has declined to comment on reports that its chairman Tan Sri Abdul Wahid Omar will be resigning early next month.
1155 4863 MLYBY MLYNF MYTEF

109
Singapore pledges to cut cash, cheques on path to digital economy

2018-06-21 malaymail
SINGAPORE, June 21 — Singapore is accelerating the shift toward digital payments by pledging to eliminate cheque usage by 2025 and slash cash withdrawals from automated telling machines.
STAN C.WSA MLYNF HSB C.WS.B D05 DBSDF STAB C.WS.A STAC SCBFF STAN C.PRP C.PRU HSBC.PRA HSBC HBCYF C.PRS HCS.PRB UOVEF DBSDY MLYBY C C.PRL C.PRJ C.PRK C.PRG HCS O39 U11 C.PRC 0005 1155 C.PRPCL CGBBW 580001 UOVEY 2888 HSEA HSEB

2
Ex-Terengganu Forestry Dept director jailed, fined for graft

2018-06-20 malaymail
KUALA TERENGGANU, June 20 — The Sessions Court today imposed a jail sentence totalling 36 months and a total fine of RM30,000 on Datuk Azmi Nordin, a former director of the Terengganu Department of Forestry, after finding him guilty on three counts of corruption in 2013.
1155 MLYBY MLYNF

10
BIMB to restructure once dust settles at Tabung Haji

2018-06-20 theedgemarkets
BIMB Holdings Bhd will likely embark on a group restructuring next year at the earliest as it waits for the dust to settle at Lembaga Tabung Haji (TH) where there is currently a boardroom shake-up, sources say.
1155 1023 1015 5258 MLYBY 6139 MLYNF AMMHF BSMAF 1818 CIMDF

8
No cap on civil servants’ debt service ratio for mortgages — Bank Negara

2018-06-20 theedgemarkets
KUALA LUMPUR: Bank Negara Malaysia (BNM) has highlighted that commercial banks have “considerable flexibility” to decide on mortgage approvals.
1155 PBLOF MLYBY MLYNF 5819 1295

10
KLCI snaps losing streak, tracks rebound at regional markets

2018-06-20 theedgemarkets
KUALA LUMPUR (June 20): The FBM KLCI snapped its losing streak and rose in early trade this morning, tracking the rebound at most regional markets.
HLFBF PBLOF MLYBY MLYNF UPBMF 1082 7113 TPGVF 1295 2089 5014 TGLVY 1155 MYPRY GEBHF

11
Casualties of US-China trade war, Bursa extends loss

2018-06-19 thestar.com.my
Stocks tumble: The Hang Seng Index closed at 29,468.15, a loss of 2.78, in Hong Kong yesterday. Hong Kong and Shanghai stocks led a sell-off across Asian and European markets on rising fears of a trade war after Trump threatened fresh tariffs on Chinese imports and Beijing warned of countermeasures. — AFP
APEXF PBLOF 7090 MLYBY MLYNF UPBMF 1295 2089 1155 BSMAF 3719 1929 1818

8
Bank Negara: No cap on civil servants’ debt service ratio for housing loans

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): Bank Negara Malaysia (BNM) has highlighted that commercial banks have “considerable flexibility” to decide on approving mortgages.
1155 PBLOF MLYBY MLYNF 5819 1295

28
SE Asian stocks decline; worsening US-China trade spat unnerves investors

2018-06-19 theedgemarkets
(June 19): Southeast Asian stock markets declined on Tuesday, with Thailand and Vietnam closing more than 2% lower, as escalating US-China trade tensions led to a broad sell-off in regional equities.
JGSMY DBSDY PBLOF SVTMF MLYBY JGS MLYNF BDOUY SM 1295 O39 BDOUF 1155 BDO D05 SMIVY DBSDF JGSHF

7
Major shake-out at GLCs and public institutions

2018-06-19 theedgemarkets
A new broom sweeps clean. Less than a month after the Pakatan Harapan government was formed, the pace of the leadership shake-out at public institutions and government-linked companies (GLCs) has been astonishing.
1155 4588 4863 MLYBY SMEBF MLYNF 4197 MYTEF

14
KLCI extends loss, drops 0.65% as banks drag

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): The FBM KLCI extended its loss at the midday break today and dropped 0.65%, dragged by banking heavyweights Public Bank Bhd and Malayan Banking Bhd (Maybank).
HLFBF APEXF PBLOF 7090 MLYNF 7113 4065 TPGVF 1295 2852 3026 3301 2836 MLYBY 1082 5681 0096 5202 7123 TGLVY 1155 4588 1996 0026 3719

4
UEM Sunrise to expand RTO scheme

2018-06-18 thestar.com.my
Managing director and chief executive officer Anwar Syahrin Abdul Ajib(pic) described UEM Sunrise RTO scheme as a value-added solution for those planning to buy a house but were in the midst of building their careers
1155 5148 MLYBY MLYNF

22
KLCI narrows loss, but remains in the red as Genting, CIMB weigh

2018-06-14 theedgemarkets
KUALA LUMPUR (June 14): The FBM KLCI narrowed its losses at market close today, but remained in the red in line with its regional peers, dragged by losses at Genting-related stocks and CIMB Group Holdings Bhd.
7251 MLYNF 5197 BATS 4162 GMALY 0133 1023 4715 PNAGF GEBHF HRGHY MLYBY SPMXF GMALF 5681 SNHHF 6432 5168 6033 CIMDF 5139 1155 PNADF SPMXY 0900 BSMAF 1818

2
Maybank sees e-Duit Raya transaction value doubling this year

2018-06-13 theedgemarkets
KUALA LUMPUR (June 13): Malayan Banking Bhd (Maybank) is expecting a 100% increase in the value of 'e-Duit Raya' transactions to RM2.7 million this year from RM1.3 million last year.
1155 MLYBY MLYNF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...